SBC Medical GroupSBC.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, SBC Medical Group (SBC.O) trades at a P/E of 10.80x, P/B of 2.02x, P/S of 3.03x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 35th percentile over the trailing 10Y window (vs. 46th percentile over 3Y); P/B sits at the 55th percentile over the trailing 10Y window (vs. 58th percentile over 3Y); P/S sits at the 98th percentile over the trailing 10Y window (vs. 98th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 18th percentile within its industry and the 22nd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.94%, ranking at the 81st percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 20.0 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here lean heavily on buybacks rather than cash dividends. SBC Medical Group operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: SBC · SBC
Want the full picture on whether SBC Medical Group (SBC.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 10.80 | ||||||
| P/B (MRQ) | 2.02 | ||||||
| P/S (TTM) | 3.03 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.94% |